Abbott (NYSE:ABT) said today that it inked a partnership deal with the National Institutes of Health to support the Brain Research through Advancing Innovative Neurotechnologies, or BRAIN initiative.
The NIH’s BRAIN initiative aims to accelerate neuroscience research and advancements, Chicago-area based Abbott said.
